Illumina Inc. (NASDAQ: ILMN) today unveiled PromoterAI, a new AI algorithm that accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome. A study ...

Alphabiome's proprietary algorithm analyzed trillions of genetic data points and identified over 10,000 complex microbe-derived biomarkers related to the successful use of these drugs.

U of T researchers have developed a deep learning algorithm that can track proteins to help reveal what makes cells healthy and what goes wrong in disease. From self-driving cars to computers that can ...